|
Symbol
|
IHTEFG | HZJEFG | Z09YGZ | RMA3QV | RMBRKV | ABMUTQ | Z0ARNZ | CQWBKB | PWCRCH | LYXRCH | LYZRCH | UJERWU | CZOBKB | RMBU5V | ACZESQ | QXPRCH | RMAKZV | QZKRCH | RLOAWV | Z0BMNZ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Reverse Convertible | Reverse Convertible | Autocallable Reverse Convertible Defensive worst | Multi Vonti | Reverse Convertible | Multi Reverse Convertible | Autocallable Reverse Convertible Defensive worst | Reverse Convertible | Autocallable Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Reverse Convertible | GOAL | Reverse Convertible | Multi Vonti | Reverse Convertible | Worst of Callable Reverse Convertible | Multi Vonti | Worst of Callable Reverse Convertible | Reverse Convertible | ZKB Reverse Convertible on worst of Last Look |
|
Underlying
|
Compagnie Financière Richemont SA / Lonza Group N / Sonova Hldg. AG / Swiss RE AG / Swisscom N | Lonza Group N / Roche PS / Sika AG | Compagnie Financière Richemont SA / Lonza Group N / Schindler PS / Sika AG | Alcon / Lonza Group N / Novartis AG / Roche PS / Sandoz Group AG | Bucher Industries AG / Lonza Group N / Sika AG | Clariant AG / Comet Hldg. AG / Lonza Group N / OC Oerlikon N / Swatch Group I | Holcim/Amrize Basket / Lonza Group N / Sandoz Group AG | Lonza Group N / Novartis AG / Roche PS / Straumann Hldg. AG | Kühne & Nagel Intl. AG / Logitech International SA / Lonza Group N / Swiss RE AG / UBS Group AG | Logitech International SA / Lonza Group N / Partners Group Hldg. AG / Sika AG | Lonza Group N / SGS S.A. Ltd. / Swisscom N | Bachem Hldg. AG / Lonza Group N / Straumann Hldg. AG | Julius Baer Group / Kühne & Nagel Intl. AG / Lonza Group N / Partners Group Hldg. AG / UBS Group AG | Lonza Group N / Novartis AG / Straumann Hldg. AG / Ypsomed Hldg. AG | Compagnie Financière Richemont SA / Lonza Group N / Partners Group Hldg. AG / UBS Group AG | Alcon / Lonza Group N / Sandoz Group AG | Lonza Group N / Sandoz Group AG / Siegfried Hldg. AG | Lonza Group N / Novartis AG / Roche PS / Sandoz Group AG | Lonza Group N | Barry Callebaut AG / Lonza Group N / UBS Group AG |
|
Issuer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date of maturity
|
28.06.2029 | 02.11.2026 | 27.08.2027 | 09.11.2026 | 05.11.2026 | 20.12.2029 | 25.08.2026 | 13.03.2028 | 27.06.2029 | 07.10.2026 | 14.07.2027 | 02.08.2027 | 15.08.2028 | 22.02.2027 | 25.08.2027 | 25.08.2027 | 01.09.2028 | 08.06.2027 | 24.09.2026 | 24.09.2026 |
| Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.465699 | - |
|
Strike price
|
176.28 | 182.298 | 179.883 | 56.14 | 197.80 | 6.7665 | 463.386 | 78.705 | 89.05 | 831.20 | 361.14 | 75.3422 | 570.50 | 70.63 | 718.90 | 52.905 | 65.00 | 425.25 | 465.70 | 799.20 |
| Max. yield p.a. | - | - | 12.25% | 12.31% | 41.84% | - | - | 7.82% | 6.34% | 134.32% | 1.44% | - | 8.08% | 4.56% | 16.73% | 9.82% | 6.01% | 4.87% | 0.45% | -0.66% |
| Bid | 93.27 | 95.65 | 93.68 | 98.00 | 92.90 | 89.03 | - | 96.30 | 95.26 | 87.43 | 100.56 | 95.55 | 92.35 | 99.30 | 89.64 | 96.20 | 95.30 | 100.48 | 100.10 | 106.31 |
| Ask | - | - | 94.58 | 98.80 | 93.70 | 89.83 | - | 97.10 | 96.06 | 88.23 | 101.37 | 96.55 | 93.15 | 100.10 | 90.44 | 97.00 | 96.10 | 101.29 | 100.30 | 107.06 |